Apply for active substance renewal by the deadlines to keep products on the NI market. Under the EU Biocidal Products Regulation (EU BPR), active substance approvals will expire unless a renewal application is submitted to ECHA at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under EU BPR. This affects NI: 29 June 2025 - Copper, granulated (CAS 7440-50-8 EC 231-159-6) in product type 8
29 March 2026 - Peracetic acid (CAS 79-21-0 EC 201-186-8) in product types 1, 2, 3, 4, 5 and 6
28 September 2026 - Fludioxonil (CAS 131341-86-1 EC 603-476-3) in product types 7, 9 and 10
Any person, company or task force/consortium can support an active substance/product type combination for renewal â it doesnât have to be the original supporter.
Check the EU Article 95 List to see who the original supporters were If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under EU BPR, the approvals will expire. This means the active substances will no longer be able to be used in biocidal products of the relevant product types. In addition, articles treated with such products will no longer be able to be placed on the market. Biocidal products must be phased off the NI market. The active substance/product type combination listed is due to expire under EU BPR on the following date. This affects NI: 30 June 2025 - 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10
Once the approval expires, the active substance will no longer be able to be used in biocidal products of the relevant product types. In addition, articles treated with such products will no longer be able to be placed on the market. If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of the active substance/product type combinations listed, please contact us. | 
